An Efficacy and Safety Study of SRM003 in the Treatment of Subjects Undergoing Creation of an Arteriovenous Fistula to Facilitate Hemodialysis Access

PHASE2CompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

March 26, 2013

Primary Completion Date

October 27, 2014

Study Completion Date

October 27, 2014

Conditions
Arteriovenous Fistula
Interventions
BIOLOGICAL

SRM003

One time implant (2 SRM003 pieces) on surgery day.

OTHER

Participating Site's standard practice

Subjects will receive sites' standard practice treatment during the surgical procedure.

Trial Locations (47)

10029

Mount Sinai School of Medicine Lab, New York

10467

Montefiore Medical Center, The Bronx

13790

United Health Services, Johnson City

19104

Penn Medicine, Perelman Center for Advanced Medicine, Philadelphia

19118

Delaware Valley Nephrology and Hypertension Associates, PC, Philadelphia

19140

Temple University School of Medicine, Philadelphia

23507

Sentara Vascular Specialists, Norfolk

27834

ECU Department of Nephrology and Hypertension, Greenville

28204

Metrolina Nephrology Associates, PA, Charlotte

29118

SC Nephrology & Hypertension Center, Inc., Orangeburg

30912

Georgia Regents University, Augusta

33606

Tampa General Hospital, Tampa

37205

Nephrology Associates, P.C., Nashville

37403

Erlanger Hospital Pharmacy, Chattanooga

40202

University of Louisville, Louisville

43210

The Ohio State University, Columbus

43560

Toledo Hospital, Toledo

44195

The Cleveland Clinic Foundation, Cleveland

45267

University of Cincinnati Physicians Company, Cincinnati

48075

Providence Hospital, Research Dept., Southfield

48202

Henry Ford Hospital, Detroit

48236

Renaissance Renal Research Institute, LLC, Detroit

49770

McLaren Northern Michigan Hospital-NISUS Research, Petoskey

53792

University of Wisconsin, Madison

58122

Sanford Research/USD-Fargo, Fargo

61603

Illinois Kidney Disease & Hypertension Center, Peoria

63110

Washington University School of Medicine, St Louis

64111

Clinical Research Consultants, LLC, Kansas City

70115

Ochsner Baptist Medical Center, Clinical Trials Unit, New Orleans

71130

Louisiana State University Health Science Center Shreveport, Shreveport

77030

Baylor College of Medicine ICTR, Houston

80045

University of Colorado Denver, Aurora

85012

Akdhc Medical Research Services, Phoenix

85745

Tucson Vascular Consultants, Tucson

89511

Sierra Nevada Nephrology Consultants, Reno

90025

The Regents University of California Los Angeles, Los Angeles

90822

VA Long Beach Health Care System Pharmacy, Long Beach

91942

California Institute of Renal Research, La Mesa

92123

California Institute of Renal Research, San Diego

93710

Ladenheim Dialysis Access Center, Fresno

94143

University of California, San Francisco, San Francisco

97210

Northwest Renal Clinic, Inc., Portland

97267

Kaiser Permanente Northwest, Milwaukie

98801

Wenatchee Valley Medical Center, Wenatchee

06520-8042

Yale University School of Medicine, New Haven

01199

Baystate Medical Center Pharmacy, Springfield

05401

Fletcher Allen Health Care Renal Service, Burlington

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Shire

INDUSTRY

NCT01806545 - An Efficacy and Safety Study of SRM003 in the Treatment of Subjects Undergoing Creation of an Arteriovenous Fistula to Facilitate Hemodialysis Access | Biotech Hunter | Biotech Hunter